ヘルプ
ヘルプ

検索結果 8,679 件

Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma 25 18

書影書影書影
Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma 25 18
デジタル博士論文障害者向け資料あり
片木, 宏昭2019Clinical Cancer Research
国立国会図書館

Clinical Cancer Research

Clinical Cancer Research
紙雑誌
American Association for Cancer Research<Z54-H820>
国立国会図書館全国の図書館
  •  
  •  
  •  
  •  
  •  
    •  

Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy

Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy
デジタル記事
2023-03-28Clinical Cancer Research29 12p.2239-2249
全国の図書館
  • 掲載誌（ISSN）10780432

Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort

Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
デジタル記事
2023-02-02Clinical Cancer Research29 8p.1460-1467
全国の図書館
  • 掲載誌（ISSN）10780432

Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation

Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation
デジタル記事
2022-11-02Clinical Cancer Research29 1p.165-173
全国の図書館
  • 掲載誌（ISSN）10780432

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study
デジタル記事
2022-10-25Clinical Cancer Research29 1p.110-121
全国の図書館
  • 掲載誌（ISSN）10780432

Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
デジタル記事
2022-10-13Clinical Cancer Research28 24p.5419-5430
全国の図書館
  • 掲載誌（ISSN）10780432

Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer

Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer
デジタル記事
2022-09-27Clinical Cancer Research28 23p.5136-5148
全国の図書館
  • 掲載誌（ISSN）10780432

Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer

Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer
デジタル記事
2022-08-03Clinical Cancer Research28 21p.4820-4831
全国の図書館
  • 掲載誌（ISSN）10780432

Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
デジタル記事
2022-07-21Clinical Cancer Research28 18p.4146-4157
全国の図書館
  • 掲載誌（ISSN）10780432

DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
デジタル記事
2022-07-08Clinical Cancer Research28 17p.3824-3835
全国の図書館
  • 掲載誌（ISSN）10780432

Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer

Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer
デジタル記事
2022-06-29Clinical Cancer Research28 17p.3797-3803
全国の図書館
  • 掲載誌（ISSN）10780432

Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Multikinase Inhibitors for Patients with Advanced Gastric Cancer with or without Liver Metastases in Clinical Trials

Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Multikinase Inhibitors for Patients with Advanced Gastric Cancer with or without Liver Metastases in Clinical Trials
デジタル記事
2022-06-09Clinical Cancer Research28 16p.3480-3488
インターネットで読める全国の図書館
  • 掲載誌（ISSN）10780432

Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study

Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study
デジタル記事
2022-06-03Clinical Cancer Research28 16p.3489-3498
全国の図書館
  • 掲載誌（ISSN）10780432

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
デジタル記事
2022-06-02Clinical Cancer Research28 16p.3464-3472
全国の図書館
  • 掲載誌（ISSN）10780432

Nivolumab Retreatment in Non–Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L)

Nivolumab Retreatment in Non–Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L)
デジタル記事
2022-05-26Clinical Cancer Research28 15p.3207-3213
インターネットで読める全国の図書館
  • 掲載誌（ISSN）10780432

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
デジタル記事
2022-05-23Clinical Cancer Research28 14p.3066-3075
全国の図書館
  • 掲載誌（ISSN）10780432

Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects <i>In Vivo</i> Expansion and Disease Response in Patients with Large B-cell Lymphoma

Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects <i>In Vivo</i> Expansion and Disease Response in Patients with Large B-cell Lymphoma
デジタル記事
2022-05-18Clinical Cancer Research28 15p.3378-3386
全国の図書館
  • 掲載誌（ISSN）10780432

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data
デジタル記事
2022-05-05Clinical Cancer Research28 13p.2844-2853
全国の図書館
  • 掲載誌（ISSN）10780432

The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents

The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents
デジタル記事
2022-04-21Clinical Cancer Research28 15p.3185-3195
全国の図書館
  • 掲載誌（ISSN）10780432